Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB-NOLI vs SABRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB-NOLI vs SABRIL: Safety Overview

Metric	ROZANOLIXIZUMAB-NOLI	SABRIL
Total FAERS Reports	349	772
Deaths Reported	4	53
Death Rate	1.1%	6.9%
Hospitalizations	84	180
Average Patient Age	55.1 yrs	11.0 yrs
% Female Patients	63.3%	N/A
Marketing Status	Prescription	N/A